This Pot Stock Just Got Listed on the NYSE: That’s Big News

CannTrust Holdings Inc (TSX:TRST)(NYSE:CTST) just got listed on the NYSE, but investors should be paying attention to another key development.

edit Cannabis leaves of a plant on a dark background

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn moresdf

In late February, CannTrust Holdings (TSX:TRST)(NYSE:CTST) began trading on the NYSE.

While a simple exchange listing may not seem that exciting, it is. With the cross-border listing, CannTrust has access to billions in additional capital. Now, retail investors that only have access to U.S.-listed stocks can buy shares.

Additionally, many mutual funds have mandates that limit their ability to purchase foreign-listed stock. With its NYSE listing, the floodgates have opened for CannTrust.

Apart from the NYSE listing, there’s one other factor you need to pay attention to. Read on to learn more.

A momentous 2018 with a caveat

At the close of 2018, Fool contributor Sean Williams did a terrific roundup of CannTrust’s biggest accomplishments that year. They included

  • The partial launch of the Niagara Greenhouse facility
  • Four recreational brands introduced
  • A push into alternative sales channels
  • The appointment of a new CEO

I strongly encourage you to read his full article, but I want to dive deeper into perhaps the most exciting development: the launch of branded cannabis.

You may have seen many of the headlines calling out specific cannabis markets that are wildly over-supplied. For example, in January, news headlines wrote that Oregon was “drowning in one million pounds of excess weed.” That month, I reported that “the inability for Oregon producers to export their product has put the entire statewide industry in chaos.”

Sure, demand is rising exponentially due to legalization, but as with any commodity, producers were rushing to bring new supply online, leading to pricing crashing across several localized markets.

Take a look at any cannabis company’s investor presentation today. What you’ll notice across nearly every pitch is their aggressive pursuit to bring on additional capacity. While cannabis bulls expect rising demand to soak up all of this supply and then some, we’re already seeing cases where that’s simply not true.

Prices will come down, ruining the bright prospects of many cannabis producers. The ones that will survive best are those with pricing power. How do you maintain pricing power in a commodity? The answer is simple: branding.

Stick with branded cannabis

Brands are incredibly powerful, providing the healthiest profit margins of any product or service. Take Coca-Cola Co for example. Its products are built with commodities, largely water and sugar. Yet Coca-Cola can charge orders of magnitude more than their cost due to branding.

It’s still unclear whether branding will work for cannabis, or which brands will win, but if you invest in cannabis companies that aren’t focused on building brands, the future will be tough as prices come down.

Last May, CannTrust launched three new brands: Liiv, Synr.g, and Xscape. As Sean Williams wrote in his piece, these brands “are focused on creating an emotional connection with the consumer, which’ll become more important as dispensaries become crowded with product.”

Investors are excited about CannTrust’s NYSE listing, and for good reason. Even more exciting, however, is the company’s nascent but growing brand portfolio. That’s where the real profits will come from.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Ryan Vanzo has no position in any stocks mentioned.

More on Cannabis Stocks

Cannabis smoke
Cannabis Stocks

Canopy Growth Stock: Is Now a Good Time to Invest?

The road ahead is highly uncertain for Canopy Growth, as the stock is plagued with losses and seemingly unsurmountable industry…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

TLRY Stock: Should You Invest Now?

TLRY is a Canadian cannabis stock which is trading 91% below record highs. Let's see if you should own TLRY…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Is Tilray Stock a Buy in February 2023?

Despite the volatile cannabis sector, Tilray could be a superb buy for long-term investors.

Read more »

Young woman sat at laptop by a window
Cannabis Stocks

Is SNDL Stock a Buy in February 2023?

SNDL is a beaten-down cannabis stock. While its revenue growth is exceptional, a weak balance sheet has driven stock prices…

Read more »

A cannabis plant grows.
Cannabis Stocks

TLRY Stock: Here’s What’s Coming in 2023

Tilray Inc. (TSX:TLRY) is geared up for big growth this decade and looks like one of the top cannabis stocks…

Read more »

A person holds a small glass jar of marijuana.
Cannabis Stocks

Canopy Growth Stock: Here’s What’s Coming in 2023

Canopy Growth stock has made a lot of new moves in the last few months, but where is the company…

Read more »

A cannabis plant grows.
Cannabis Stocks

Better Cannabis Buy: Canopy Growth Stock or Tilray?

Only two TSX weed stocks can deliver substantial returns in the highly anticipated growth of the global cannabis market.

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

Is Tilray Stock a Buy in January 2023?

Tilray stock has lost 50% of its value in the last 12 months, in line with its peers.

Read more »